Sponsors
Click here for Sponsorship online
Nobel-Pauling thanks to our sponsor MangoTango Minecraft Roleplay (www.Youtube.com/MangoTango) for supporting 2017 and 2018 Pauling Biotech Christmas Symposium and 2016 Linus-Pauling Biologics Symposium.
For 2016 Biotech Symposium, we also thank MIT Audio Visual (Brian Magoon and Andie Browne) and Dr. Paulo Garcia, Research Scientist at MIT for helping projector and microphones so that speakers can give seminars with slide presentation at the Pauling Biologics Symposium. We also thank our sponsors, Dr. Michael Blank, CSO, AptaIT GmbH, Munich, Germany (www.aptait.de), Dr. Andreas Schaaf, CSO, Greenovation Biotech, Germany (www.greenovation.com), Dr. Qing Liao, CEO of Boston Paragon and CSO of Spire Metering Technology (www.spiremt.com) and Dr. Grace, CEO of ActoKine Therapeutics (www.actokine.com), Dr. Ravi Kumar, CSO, Acceleron Pharma (www.AcceleronPharma.com), Wolf-Greenfield (www.wolfgreenfield.com), MangoTango Minecraft Roleplay (www.Youtube.com/MangoTango) and TheIronMango Minecraft (www.YouTube.com/TheIronMango) for their sponsorship to partialy cover the dinner for speakers, students, postdocs and volunteers for 2016 Biotech Symposium.
We thank our sponsors TheIronMango (www.YouTube.com/TheIronMango) and MangoTango Minecraft Roleplay (www.Youtube.com/MangoTango) for supporting 2015 Nobel-Pauling Biotech Christmas Symposium. We also thank MIT Audio Visual (Brian Magoon) and Dr. Jiang He, postdoc at MIT for helping projector and microphones so that speakers could give seminars with slide presentation at the 2015 Linus Pauling Christmas Symposium.
We thank our our sponsors (Dr. Chiang Li, CEO, Boston BioMedical, www.bostonbiomedical.com, Pardee’s Post-doc); Dr. Kathy Martin (Founder & President, KJMBiosystems, www.kjmbiosystems.com and Founder, Bioarray Therapeutics, Pardee’s post-doc); Frank Pan and Becky Buzzeo (ThermoFisher Scientific), Dr. James Falls (GSK) and Dr. DeLise Falls (University of North Carolina) for supporting 2014 Nobel-Pauling Biotech microRNSA Symposium on March 17, 2014, Boston.
 |
Roche (www.rocheusa.com, Nutley, New Jersey, USA, for 2011 symposium )Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is a member of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years, Roche has built a legacy of innovation decade by decade, discovery by discovery, and we continue to focus on developing new, innovative and clinically differentiated medicines that are beneficial for healthcare professionals and patients.To maintain our innovative focus, the 127-acre site in New Jersey is expanding its research base and will become one of the largest R&D centers for Roche. Nutley is the center for the Oncology, Inflammation and Virology Discovery and Translational Areas (DTAs). These areas have a rich pipeline comprised of novel first-in-class and best-in-class compounds and have at their disposal the expertise of scientists in Discovery Technologies. |
 |
Sanofi (www.sanofi-aventis.com, Cambridge, USA, for 2011 symposium)Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health. |
 |
Abbott (www.abbott.com, Worcester, MA, USA, for 2012 symposium)At Abbott Bioresearch Center (ABC) in Worcester, we’re making new discoveries every day. We’re innovating and developing the medicines that change the world of patient health. ABC is a unique facility housing about 700 employees engaged in both research and manufacturing. Research capabilities are focused on biologic and small molecule drug discovery for several therapeutic areas including immunology, neuroscience and oncology. Our researchers have the freedom and ingenuity to target prime diseases, combining the innovative spirit of biotechnology with the stability of a pharmaceutical company. |
 |
Immudex (www.immudex.com, Denmark, for 2012 symposium)Immudex develops and commercializes products for the quantitation, characterization, and generation of antigen-specific T-cell responses for life science research, in vitro diagnostics and vaccine development. Immudex’s marketed products as well as its products under development are based on Immudex’s proprietary Dextramer technology; immobilization of MHC molecules and other immunologically relevant molecules onto a dextran backbone. Compared to traditional MHC multimer reagents, the higher valency of MHC Dextramers enables more efficient detection of antigen-specific T-cells and better detection of lower avidity T-cell clones. The increased signal-to-noise ratio provided by Dextramer reagents enables clear separation of T-cell populations left ambiguous by the earlier generation of multimer reagents. Immudex’s vaccine candidate targets one of the most prevalent, virally-derived human diseases. Benefit to humankind and commercial potential of this project are enormous. Preclinical trials of our technology in a monkey model have generated exciting results. Improvement of the human condition through immunotechnology is our goal. Dextramer technology is our tool. We are Immudex.
|
 |
Eincobio (www.eincobio.com.br, Brazil, for 2011 symposium)Eincobio is a genuine Brazilian company, pioneered since 1985 in the area of bioengineering for the repair, reconstruction and regeneration of organs, systems and living tissues focusing mainly on bone.The company combines specialized knowledge with high technology and the development of Biosolutions, based on the organic principles. These biosolutions favor natural interactions with substances and structures of the body and lead to distinctions that transform OSTEOSYNT into an innovative technology that is a worldly market reference in the recons-truction of bone tissue. EincoBio also manufactures customized pieces, providing flexibility and accurate solutions attending the doctors and the patients needs. They were the first products with these characteristics to be registered in Brazil and to have their commercialization standardized and regulated. EincoBio has patented their materials in 1991 (IPI 9104220-8), along with the bone morphogenetic complex and its principles. Besides manufacturing and commercializing OSTEOSYNT, EincoBio is a raw material supplier for biotechnology companies that develop complementary products and also performs licensing of product purchasing with specific marks. The group responsible for EincoBio has a strong presence in the area of biotechnology. By supporting and creating partnership with renowned institutions in Brazil and abroad, EincoBio promotes and consolidates the technological autonomy of the Country in the area of biotechnology. It has founded the Brazilian Institute of Biomaterials – IBB, and the Latin-American Society of Biomaterials and Artificial Organs – SLABO. 
|
 |
Neuland (www.neulandlabs.com, India, for 2011 symposium)Neuland Laboratories is a contract research and manufacturing organization based in Hyderabad, India, and offers R&D, process optimization and development services, and cGMP production of pre-clinical through commercial stage small molecule intermediates, NCEs and APIs. Neuland has been providing high quality API development and manufacturing services to the Pharmaceutical and Biotech industries for over 27 years, and has supported a number of IND, NDA and MAA filings.Neuland’s unique on-line project management system, Concerto, has revolutionized the way the chemistry & manufacturing projects are handled and viewed by our clients. As a result of this system, which allows Neuland to manage our resources internally to ensure on-time-delivery, Neuland’s clients have real-time-access to daily updates on their projects. This offers Neuland’s clients a level of transparency, flexibility and reliability that very few service providers can match. Neuland has scaled up over 300 chemical processes from the lab to commercial production scale, has developed over 50 Active Ingredients (generic and New Chemical Entities) and filed over 400 Drug Master Files worldwide. Neuland's facilities have been inspected by the vast majority of the leading regulatory agencies in the world including: US FDA, EDQM, PMDA (Japan), KFDA (Korea), TGA (Australia) and the German Health Authorities, among others. |
 |
Novoprotein (www.novoprotein.com, Shanghai, China, for 2011 symposium)Novoprotein is a leading contract research biotech company dedicated solely to recombinant protein service and product. Novoprotein possesses advanced technology and extensive experience in the field and offers a comprehensive service portfolio, from protein expression, antibody production, protein modification, and protein crystallization. Novoprotein has accomplished over 1000 contract projects with an 85% success rate, and has developed a catalog of more than 500 enzymes and cytokines since its inception in 2004.
|
 |
Dongguan China (http://dgfao.dg.gov.cn, Dongguan, China, for 2010 and 2011 symposium)
|
 |
OriGene (www.OriGene.com, MD, USA, for 2011 symposium )OriGene Technologies was founded in 1996 in Rockville, Maryland with the goals to create the largest commercial collection of full-length human cDNA s. Our flagship product is 25,000 TrueORF human cDNA clones.Over the last five years, OriGene has experienced significant growth. From cDNA clones, we have developed the largest offering of full length human protein expressed in mammalian cells. In 2010, OriGene initiated the TrueMAB project to develop mouse monoclonal antibodies for every human protein. Since 2008, OriGene has acquired 4 companies to compliment our gene-centric business strategy, including P&A for monoclonal antibody, Cytomyx for biorepository, Marligen for Luminex assays, and Blue Heron for gene synthesis. OriGene is committed to its mission to be “Your Gene Company”, in supplying everything a researcher needs for gene based research. 
|
 |
Hong Kong Science & Technology Parks (www.hkstp.org, Hong Kong, for 2010 symposium)Hong Kong Science and Technology Parks Corporation (HKSTPC) is a statutory body set up by the Government of the Hong Kong Special Administrative Region. HKSTPC provides innovative and technology driven infrastructure and support facilities which include market focused clustered laboratory services enabling Hong Kong industries and services to be more competitive; it provides a full-service incubation programme for technology and design start-ups, and fosters partnerships and collaboration between industry and universities/applied research institutes through consulting, training and research programmes. HKSTPC offers advanced facilities and support services for high technology companies that include an IC Design Centre, an IC Development Support Centre, a Materials Analysis Laboratory, a Wireless Communications Test Laboratory, an Intellectual Property Servicing Centre, a Solar Energy Technology Support Centre and a Biotech Centre.
|
 |
Huabo Biopharm (website under development, Shanghai, China, for 2011 symposium)Huabo Biopharm, a wholly owned subsidiary of Huahai Pharmaceutical, is a start-up biotech company dedicated to discovery, development, and commercializing of breakthrough therapies with the potential to deliver meaningful clinical benefit to tumor patients. The management team is consisted of several over-sea scholars and all have profound knowledge and comprehensive experiences both in industrial as well as in academic area. We are committed to excellence and strike to make a difference every day. We are currently advancing a pipeline of promising preclinical candidates and have robust research capabilities fuelling our long-term growth. |
 |
GENEWIZ (http://www.genewiz.com, USA, for 2011 symposium)Excelling in both science and service, GENEWIZ is the leading trusted partner for DNA services. Since 1999, our commitment is to advance research productivity through our distinctive combination of fast, reliable results, specialized expertise, competitive pricing, excellent project management and easy access to award-winning, friendly technical support.With state-of-the-art facilities at the local, national, and international levels, we value our loyal customers, both high and low volume, who have made GENEWIZ an industry leader. Together we can make a difference in the pursuit of scientific discoveries, better medicines, a greener environment, and abundant and healthy food supplies. 
|
 |
Integrated DNA Technologies (www.idtdna.com, USA, for 2011 symposium)
|
 |
QIAGEN (www.QIAGEN.com, USA, for 2011 symposium)Happy Holiday wishes from QIAGEN to you and your family. As the innovative market and technology leader, QIAGEN creates sample and assay technologies that enable access to content from any biological sample. Our mission is to enable our customers to achieve outstanding success and breakthroughs in life sciences, applied testing, pharma, and molecular diagnostics. We thereby make improvements in life possible. Our commitment to the markets, customers, and patients we serve drives our innovation and leadership in all areas where our sample and assay technologies are required.The exceptional talent, skill, and passion of our employees are key to QIAGEN’s excellence, success and value.
|
For past Symposium Sponsors please visit www.pauling.us and www.studentvision.org
